Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1554
| Despition | Human FGF1 (Active) |
| SIZE | 500U |
| Source | Recombinant |
| Protein Species | Human |
| Molecular Weight | 15.3kDa |
| Purity | > 95% by SDS-PAGE. |
| Form | Lyophilized |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1254 | Luteinizing Hormone Blocking Peptide (AC1254) | 250 µg | inquiry |
| ACPP-1762 | Human SNAP25 Protein, His (AC1762) | 10 µg | inquiry |
| ACPP-1548 | Human FGF 19 Protein, His (AC1548) | 5 µg | inquiry |
| ACPP-1699 | Human Human Prealbumin (Active) Protein (AC1699) | 1 mg | inquiry |
| ACPP-1014 | Recombinant Human P Cadherin Protein (6×His Tag) (AC1014) | 50 µg | inquiry |
| ACPP-1697 | Mouse Midkine Protein (AC1697) | 5 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1056 | Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) | 50 µg | inquiry |
| ACPP-1797 | Human S100A5 Protein (AC1797) | 5 µg | inquiry |
| ACPP-1813 | Human HAAO Protein (AC1813) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.